Schedule 13G Filing for NRx Pharmaceuticals, Inc.

The Schedule 13G filing reports that The B Group, Inc., B Group Capital LLC, and Branden B. Muhl collectively own 3,000,000 shares of NRx Pharmaceuticals, Inc.'s Common Stock, representing 12.62% of the outstanding shares. The B Group, Inc. serves as the investment adviser to B Group Capital LLC, and Branden B. Muhl is the controlling person and manager of both entities. The filing is made pursuant to Rule 13d-1(c) and includes a Joint Filing Agreement, indicating that the reporting persons are jointly filing this statement. The shares are not held for the purpose of influencing the control of the issuer.